Q8VHJ5
Gene name |
Mark1 (Emk3, Kiaa1477) |
Protein name |
Serine/threonine-protein kinase MARK1 |
Names |
EC 2.7.11.1 , EC 2.7.11.26 , ELKL motif serine/threonine-protein kinase 3 , MAP/microtubule affinity-regulating kinase 1 , PAR1 homolog c , Par-1c , mPar-1c |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:226778 |
EC number |
2.7.11.1: Protein-serine/threonine kinases |
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
60-311 (Protein kinase domain) |
Relief mechanism |
Others |
Assay |
|
Accessory elements
199-221 (Activation loop from InterPro)
Target domain |
60-311 (Protein kinase domain) |
Relief mechanism |
|
Assay |
|
199-221 (Activation loop from InterPro)
Target domain |
60-311 (Protein kinase domain) |
Relief mechanism |
|
Assay |
|
Autoinhibited structure

Activated structure

1 structures for Q8VHJ5
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q8VHJ5-F1 | Predicted | AlphaFoldDB |
33 variants for Q8VHJ5
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs33826721 | 40 | L>I | No | EVA | |
rs3388517671 | 65 | T>R | No | EVA | |
rs3388517926 | 70 | N>K | No | EVA | |
rs3388524945 | 109 | R>Q | No | EVA | |
rs3388522282 | 245 | V>A | No | EVA | |
rs3390996633 | 249 | T>A | No | EVA | |
rs3388522269 | 265 | L>H | No | EVA | |
rs3388522275 | 284 | C>Y | No | EVA | |
rs3388521065 | 286 | N>I | No | EVA | |
rs3388523810 | 301 | S>I | No | EVA | |
rs48463844 | 318 | E>D | No | EVA | |
rs3388519906 | 326 | P>L | No | EVA | |
rs3388519841 | 335 | R>T | No | EVA | |
rs3388524964 | 357 | K>I | No | EVA | |
rs3388524290 | 364 | T>I | No | EVA | |
rs3388522216 | 386 | L>V | No | EVA | |
rs3388522236 | 426 | A>T | No | EVA | |
rs3388517927 | 434 | V>L | No | EVA | |
rs3388524993 | 455 | K>* | No | EVA | |
rs3388524355 | 490 | S>N | No | EVA | |
rs3388521596 | 493 | V>A | No | EVA | |
rs211874876 | 515 | A>T | No | EVA | |
rs3388524974 | 592 | H>R | No | EVA | |
rs13476283 | 603 | R>H | No | EVA | |
rs3390917788 | 633 | S>P | No | EVA | |
rs3388524968 | 640 | A>V | No | EVA | |
rs3388523983 | 647 | G>C | No | EVA | |
rs234113235 | 674 | A>T | No | EVA | |
rs3388521601 | 687 | R>I | No | EVA | |
rs3388524959 | 704 | W>* | No | EVA | |
rs3388524018 | 716 | D>E | No | EVA | |
rs3388523425 | 752 | L>H | No | EVA | |
rs3388522181 | 771 | R>G | No | EVA |
No associated diseases with Q8VHJ5
Functions
Description | ||
---|---|---|
EC Number | 2.7.11.1 | Protein-serine/threonine kinases |
Subcellular Localization |
|
|
PANTHER Family | ||
PANTHER Subfamily | ||
PANTHER Protein Class | ||
PANTHER Pathway Category | No pathway information available |
4 GO annotations of cellular component
Name | Definition |
---|---|
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
cytoskeleton | A cellular structure that forms the internal framework of eukaryotic and prokaryotic cells. The cytoskeleton includes intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles. |
dendrite | A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
9 GO annotations of molecular function
Name | Definition |
---|---|
ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
magnesium ion binding | Binding to a magnesium (Mg) ion. |
phosphatidic acid binding | Binding to phosphatidic acid, any of a class of glycerol phosphate in which both the remaining hydroxyl groups of the glycerol moiety are esterified with fatty acids. |
phosphatidylinositol-4,5-bisphosphate binding | Binding to phosphatidylinositol-4,5-bisphosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 4' and 5' positions. |
phosphatidylserine binding | Binding to phosphatidylserine, a class of glycophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of L-serine. |
protein kinase activity | Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction |
protein serine kinase activity | Catalysis of the reactions |
protein serine/threonine kinase activity | Catalysis of the reactions |
tau-protein kinase activity | Catalysis of the reaction |
12 GO annotations of biological process
Name | Definition |
---|---|
cytoskeleton organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures. |
establishment of mitochondrion localization | The directed movement of the mitochondrion to a specific location. |
intracellular signal transduction | The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
microtubule cytoskeleton organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising microtubules and their associated proteins. |
negative regulation of epithelial to mesenchymal transition | Any process that decreases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell. |
negative regulation of gene expression | Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
neuron migration | The characteristic movement of an immature neuron from germinal zones to specific positions where they will reside as they mature. |
positive regulation of gene expression | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
protein phosphorylation | The process of introducing a phosphate group on to a protein. |
regulation of dendrite development | Any process that modulates the frequency, rate or extent of dendrite development. |
regulation of neuron projection development | Any process that modulates the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites). |
Wnt signaling pathway | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state. |
20 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q96L34 | MARK4 | MAP/microtubule affinity-regulating kinase 4 | Homo sapiens (Human) | SS |
P57059 | SIK1 | Serine/threonine-protein kinase SIK1 | Homo sapiens (Human) | PR |
Q7KZI7 | MARK2 | Serine/threonine-protein kinase MARK2 | Homo sapiens (Human) | SS |
P27448 | MARK3 | MAP/microtubule affinity-regulating kinase 3 | Homo sapiens (Human) | SS |
Q9P0L2 | MARK1 | Serine/threonine-protein kinase MARK1 | Homo sapiens (Human) | EV |
Q8C0N0 | Gm4922 | Sperm motility kinase Z | Mus musculus (Mouse) | PR |
Q8C0X8 | Sperm motility kinase X | Mus musculus (Mouse) | PR | |
A0AUV4 | Gm7168 | Sperm motility kinase Y | Mus musculus (Mouse) | PR |
Q8VBY2 | Camkk1 | Calcium/calmodulin-dependent protein kinase kinase 1 | Mus musculus (Mouse) | PR |
Q8CIP4 | Mark4 | MAP/microtubule affinity-regulating kinase 4 | Mus musculus (Mouse) | SS |
Q05512 | Mark2 | Serine/threonine-protein kinase MARK2 | Mus musculus (Mouse) | SS |
Q8CEE6 | Pask | PAS domain-containing serine/threonine-protein kinase | Mus musculus (Mouse) | SS |
Q03141 | Mark3 | MAP/microtubule affinity-regulating kinase 3 | Mus musculus (Mouse) | SS |
Q8VHF0 | Mark3 | MAP/microtubule affinity-regulating kinase 3 | Rattus norvegicus (Rat) | SS |
O08679 | Mark2 | Serine/threonine-protein kinase MARK2 | Rattus norvegicus (Rat) | SS |
O08678 | Mark1 | Serine/threonine-protein kinase MARK1 | Rattus norvegicus (Rat) | SS |
Q852Q1 | OSK4 | Serine/threonine protein kinase OSK4 | Oryza sativa subsp. japonica (Rice) | SS |
Q852Q2 | OSK1 | Serine/threonine protein kinase OSK1 | Oryza sativa subsp. japonica (Rice) | SS |
Q852Q0 | OSK3 | Serine/threonine protein kinase OSK3 | Oryza sativa subsp. japonica (Rice) | SS |
Q9TW45 | par-1 | Serine/threonine-protein kinase par-1 | Caenorhabditis elegans | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MSARTPLPTV | NERDTENHTS | VDGYTETHIP | PAKSSSRQNL | PRCRNSITSA | TDEQPHIGNY |
70 | 80 | 90 | 100 | 110 | 120 |
RLQKTIGKGN | FAKVKLARHV | LTGREVAVKI | IDKTQLNPTS | LQKLFREVRI | MKILNHPNIV |
130 | 140 | 150 | 160 | 170 | 180 |
KLFEVIETEK | TLYLVMEYAS | GGEVFDYLVA | HGRMKEKEAR | AKFRQIVSAV | QYCHQKCIVH |
190 | 200 | 210 | 220 | 230 | 240 |
RDLKAENLLL | DADMNIKIAD | FGFSNEFTVG | NKLDTFCGSP | PYAAPELFQG | KKYDGPEVDV |
250 | 260 | 270 | 280 | 290 | 300 |
WSLGVILYTL | VSGSLPFDGQ | NLKELRERVL | RGKYRIPFYM | STDCENLLKK | LLVLNPIKRG |
310 | 320 | 330 | 340 | 350 | 360 |
SLEQIMKDRW | MNVGHEEEEL | KPYSEPELDL | SDAKRIDIMV | TMGFARDEIN | DALVSQKYDE |
370 | 380 | 390 | 400 | 410 | 420 |
VMATYILLGR | KPPEFEGGES | LSSGSLCQRS | RPSSDLNNST | LQSPAHLKVQ | RSISANQKQR |
430 | 440 | 450 | 460 | 470 | 480 |
RFSDHAGPSI | PPAVSYTKRP | QANSVESEQK | EEWGKDTARR | LGSTTVGSKS | EVTASPLVGP |
490 | 500 | 510 | 520 | 530 | 540 |
DRKKSTASPS | NNVYSGGSMA | RRNTYVCERS | TDRYAALQNG | RDSSLTEMSA | SSMSSAGSTV |
550 | 560 | 570 | 580 | 590 | 600 |
ASAGPSARPR | HQKSMSTSGH | PIKVTLPTIK | DGSEAYRPGA | AQRVPAASPS | AHSISASTPD |
610 | 620 | 630 | 640 | 650 | 660 |
RTRFPRGSSS | RSTFHGEQLR | ERRSAAYNGP | PASPSHETGA | FAHARRGTST | GIISKITSKF |
670 | 680 | 690 | 700 | 710 | 720 |
VRRDPSEGEA | SGRADTARGS | SGDPKERDKD | EGKEAKPRSL | RFTWSMKTTS | SMDPNDMLRE |
730 | 740 | 750 | 760 | 770 | 780 |
IRKVLDANTC | DYEQKERFLL | FCVHGDARQD | SLVQWEMEVC | KLPRLSLNGV | RFKRISGTSI |
790 | |||||
AFKNIASKIA | NELKL |